Kenneth Bate
Director at Madrigal Pharmaceuticals, Inc. (MDGL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 1,76317,439 held (−9%) | $480.24 | $847K | -1.8% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 3,25914,180 held (−19%) | $481.13 | $1.6M | -1.9% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 1,28412,896 held (−9%) | $482.41 | $619K | -2.2% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 2,06910,827 held (−16%) | $483.41 | $1.0M | -2.4% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 1,9318,896 held (−18%) | $484.78 | $936K | -2.7% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 1,0087,888 held (−11%) | $485.54 | $489K | -2.8% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 8277,061 held (−10%) | $486.73 | $403K | -3.1% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 2,7754,286 held (−39%) | $487.49 | $1.4M | -3.2% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 6963,590 held (−16%) | $489.09 | $340K | -3.5% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 9332,657 held (−26%) | $489.95 | $457K | -3.7% |
| Nov 7SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 302,627 held (−1%) | $490.98 | $15K | -3.9% |
- Sell
Director Kenneth Bate sold $1.4M of MDGL at $487.49 — cuts the stake by 39%.
- Sell
Director Kenneth Bate sold $457K of MDGL at $489.95 — cuts the stake by 26%.